NASDAQ:ENTL - Entellus Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$24.00 0.00 (0.00 %)
(As of 06/25/2018 03:20 PM ET)
Previous Close$24.00
Today's Range$24.00 - $24.00
52-Week Range$11.47 - $25.58
VolumeN/A
Average Volume178,331 shs
Market Capitalization$611.38 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.02
Entellus Medical logoEntellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company's XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

Receive ENTL News and Ratings via Email

Sign-up to receive the latest news and ratings for ENTL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:ENTL
CUSIPN/A
Phone+1-763-4631595

Debt

Debt-to-Equity Ratio0.32
Current Ratio1.92
Quick Ratio1.71

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$75.18 million
Price / Sales8.21
Cash FlowN/A
Price / CashN/A
Book Value$1.87 per share
Price / Book12.83

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-28,710,000.00
Net Margins-31.24%
Return on Equity-47.37%
Return on Assets-27.29%

Miscellaneous

Employees280
Outstanding Shares25,730,000

The Truth About Cryptocurrencies

Entellus Medical (NASDAQ:ENTL) Frequently Asked Questions

What is Entellus Medical's stock symbol?

Entellus Medical trades on the NASDAQ under the ticker symbol "ENTL."

How were Entellus Medical's earnings last quarter?

Entellus Medical Inc (NASDAQ:ENTL) released its earnings results on Thursday, November, 3rd. The medical technology company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.37) by $0.13. The medical technology company earned $17.90 million during the quarter, compared to analysts' expectations of $17.93 million. Entellus Medical had a negative return on equity of 47.37% and a negative net margin of 31.24%. Entellus Medical's quarterly revenue was up 20.9% compared to the same quarter last year. During the same period last year, the firm posted ($0.32) EPS. View Entellus Medical's Earnings History.

What price target have analysts set for ENTL?

3 analysts have issued 12-month price targets for Entellus Medical's stock. Their forecasts range from $17.00 to $21.00. On average, they expect Entellus Medical's stock price to reach $19.00 in the next year. View Analyst Ratings for Entellus Medical.

Who are Entellus Medical's key executives?

Entellus Medical's management team includes the folowing people:
  • Robert S. White, President, Chief Executive Officer, Director
  • Brent A. Moen, Chief Financial Officer, Corporate Secretary
  • Michael H. Rosenthal, Chief Operating Officer
  • Jonelle R. Burnham, Chief Compliance Officer, Vice President, General Counsel
  • Stephen R. Paidosh, Vice President, Operations
  • Thomas D. Williamson, Vice President - Sales
  • Kevin L. Mensink, Vice President of Marketing
  • Martha J. Christian, Vice President, Reimbursement
  • Timothy B. Petrick, Vice President, Research and Development
  • Brian E. Farley, Non-Executive Chairman of the Board

When did Entellus Medical IPO?

(ENTL) raised $70 million in an initial public offering on Friday, January 30th 2015. The company issued 4,400,000 shares at a price of $15.00-$17.00 per share. BofA Merrill Lynch and Piper Jaffray served as the underwriters for the IPO and William Blair and Canaccord Genuity were co-managers.

Has Entellus Medical been receiving favorable news coverage?

Media stories about ENTL stock have been trending somewhat positive on Monday, according to Accern Sentiment. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Entellus Medical earned a news sentiment score of 0.08 on Accern's scale. They also assigned news stories about the medical technology company an impact score of 45.95 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Entellus Medical?

Shares of ENTL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Entellus Medical's stock price today?

One share of ENTL stock can currently be purchased for approximately $24.00.

How big of a company is Entellus Medical?

Entellus Medical has a market capitalization of $611.38 million and generates $75.18 million in revenue each year. Entellus Medical employs 280 workers across the globe.

How can I contact Entellus Medical?

Entellus Medical's mailing address is 3600 Holly Ln N Ste 40, PLYMOUTH, MN 55447-1286, United States. The medical technology company can be reached via phone at +1-763-4631595.


MarketBeat Community Rating for Entellus Medical (ENTL)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  178 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  317
MarketBeat's community ratings are surveys of what our community members think about Entellus Medical and other stocks. Vote "Outperform" if you believe ENTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ENTL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.